earnings
confidence high
sentiment positive
materiality 0.80
Charles River Q2 non-GAAP EPS $3.12 beats; raises 2025 guidance; DOJ closes NHP probe
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
2025-Q2 EPS
reported $1.55
vs consensus $2.52
▼ miss
(-38.6%)
- Q2 revenue $1.032B (+0.6% reported; organic -0.5%); GAAP EPS $1.06, non-GAAP EPS $3.12 up 11.4% YoY.
- Non-GAAP operating margin improved to 22.1% from 21.3%; DSA non-GAAP margin slightly up to 27.4%.
- Raises FY2025 non-GAAP EPS guidance to $9.90-$10.30 (prior $9.30-$9.80); revenue growth (2.5%)-(0.5%).
- DOJ closes grand jury and civil investigations into NHP supply chain; no action taken.
- Segment organic growth: RMS +2.3%, DSA -2.4%, Manufacturing +2.9%; cost savings from restructuring.